EMERGENT BIOSOLUTIONS INC. Increase (Decrease) in Contract with Customer, Liability
EMERGENT BIOSOLUTIONS INC. (EBS) reported Increase (Decrease) in Contract with Customer, Liability of $6.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $3.30M, a 1550.00% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $3.20M.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $4.10M.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $1.20M, a 71.43% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $5.20M.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in contract with customer, liability for fiscal 2024 was -$20.30M, a 444.07% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $5.90M, a 38.54% decline from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. increase (decrease) in contract with customer, liability for fiscal 2022 was $9.60M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 6 month as first filed | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.50M 10-Q · filed 2026-08-06 | $10.60M derived: sum of 3 quarters · filed 2026-08-06 | $11.80M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $3.20M 10-Q · filed 2026-05-01 | $7.30M derived: sum of 2 quarters · filed 2026-05-01 | $8.50M derived: sum of 3 quarters · filed 2026-05-01 | $8.70M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $5.30M derived: sum of 2 quarters · filed 2026-02-27 | $5.50M derived: sum of 3 quarters · filed 2026-08-06 | $5.20M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.40M derived: sum of 2 quarters · filed 2026-08-06 | $1.10M 10-Q · filed 2025-10-30 | -$400.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$100.00K 10-Q · filed 2026-08-06 | -$1.60M derived: sum of 3 quarters · filed 2026-08-06 | -$900.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$300.00K 10-Q · filed 2026-05-01 | -$1.80M derived: sum of 2 quarters · filed 2026-05-01 | -$1.10M derived: sum of 3 quarters · filed 2026-05-01 | -$900.00K derived: sum of 4 quarters · filed 2026-05-01 | ||
| 2024-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$800.00K derived: sum of 2 quarters · filed 2026-02-27 | -$600.00K derived: sum of 3 quarters · filed 2026-02-27 | -$20.30M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $900.00K derived: sum of 2 quarters · filed 2025-10-30 | -$18.80M 10-Q · filed 2025-10-30 | -$14.70M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$19.50M 10-Q · filed 2025-08-07 | -$15.40M derived: sum of 3 quarters · filed 2026-02-27 | -$5.90M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | -$19.70M 10-Q · filed 2025-05-08 | -$15.60M derived: sum of 2 quarters · filed 2026-02-27 | -$6.10M derived: sum of 3 quarters · filed 2026-02-27 | -$5.40M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $13.60M derived: sum of 2 quarters · filed 2026-02-27 | $14.30M derived: sum of 3 quarters · filed 2026-02-27 | $5.90M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $9.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $10.20M derived: sum of 2 quarters · filed 2024-11-07 | $1.80M 10-Q · filed 2024-11-07 | $7.20M derived: sum of 4 quarters · filed 2025-03-04 | ||
| 2023-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$7.70M 10-Q · filed 2024-08-07 | -$2.30M derived: sum of 3 quarters · filed 2025-03-04 | -$800.00K derived: sum of 4 quarters · filed 2025-03-04 | ||
| 2023-03-31 | -$8.40M 10-Q · filed 2024-05-02 | -$3.00M derived: sum of 2 quarters · filed 2025-03-04 | -$1.50M derived: sum of 3 quarters · filed 2025-03-04 | $3.20M derived: sum of 4 quarters · filed 2025-03-04 | ||
| 2022-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $6.90M derived: sum of 2 quarters · filed 2025-03-04 | $11.60M derived: sum of 3 quarters · filed 2025-03-04 | $9.60M 10-K · filed 2025-03-04 | ||
| 2022-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11 | $6.20M derived: sum of 2 quarters · filed 2023-12-11 | $4.20M 10-Q · filed 2023-12-11 | -$8.10M derived: sum of 4 quarters · filed 2024-03-08 | ||
| 2022-06-30 | $4.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.70M 10-Q · filed 2023-08-09 | -$9.60M derived: sum of 3 quarters · filed 2024-03-08 | $390.40M derived: sum of 4 quarters · filed 2024-03-08 | ||
| 2022-03-31 | -$2.00M 10-Q · filed 2023-05-10 | -$14.30M derived: sum of 2 quarters · filed 2024-03-08 | $385.70M derived: sum of 3 quarters · filed 2024-03-08 | $376.70M derived: sum of 4 quarters · filed 2024-03-08 | ||
| 2021-12-31 | -$12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $387.70M derived: sum of 2 quarters · filed 2024-03-08 | $378.70M derived: sum of 3 quarters · filed 2024-03-08 | -$31.80M 10-K · filed 2024-03-08 | ||
| 2021-09-30 | $400.00M 10-Q · filed 2021-11-05 | $391.00M derived: sum of 2 quarters · filed 2022-08-02 | -$19.50M 10-Q · filed 2022-11-09 | $420.60M derived: sum of 4 quarters · filed 2023-12-11 | ||
| 2021-06-30 | -$9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $400.00K 10-Q · filed 2022-08-02 | $20.60M derived: sum of 3 quarters · filed 2023-12-11 | -$17.50M derived: sum of 4 quarters · filed 2023-12-11 | ||
| 2021-03-31 | $9.40M 10-Q · filed 2022-04-29 | $29.60M derived: sum of 2 quarters · filed 2023-12-11 | -$8.50M derived: sum of 3 quarters · filed 2023-12-11 | $20.10M derived: sum of 4 quarters · filed 2023-12-11 | ||
| 2020-12-31 | $20.20M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | -$17.90M derived: sum of 2 quarters · filed 2023-12-11 | $10.70M derived: sum of 3 quarters · filed 2023-12-11 | $11.20M 10-K/A · filed 2023-12-11 | ||
| 2020-09-30 | -$38.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$9.50M derived: sum of 2 quarters · filed 2021-11-05 | -$9.00M 10-Q · filed 2021-11-05 | -$12.10M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-06-30 | $28.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $29.10M 10-Q · filed 2021-07-30 | $26.00M derived: sum of 3 quarters · filed 2022-02-25 | $28.70M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-03-31 | $500.00K 10-Q · filed 2021-04-30 | -$2.60M derived: sum of 2 quarters · filed 2022-02-25 | $100.00K derived: sum of 3 quarters · filed 2022-02-25 | $14.40M derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2019-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$400.00K derived: sum of 2 quarters · filed 2022-02-25 | $13.90M derived: sum of 3 quarters · filed 2022-02-25 | $16.00M 10-K · filed 2022-02-25 | ||
| 2019-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $17.00M derived: sum of 2 quarters · filed 2020-11-06 | $19.10M 10-Q · filed 2020-11-06 | $16.10M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2019-06-30 | $14.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $16.40M 10-Q · filed 2020-07-31 | $13.40M derived: sum of 3 quarters · filed 2021-02-19 | $16.50M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2019-03-31 | $2.10M 10-Q · filed 2020-05-01 | -$900.00K derived: sum of 2 quarters · filed 2021-02-19 | $2.20M derived: sum of 3 quarters · filed 2021-02-19 | $8.80M derived: sum of 4 quarters · filed 2021-02-19 | ||
| 2018-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $100.00K derived: sum of 2 quarters · filed 2021-02-19 | $6.70M derived: sum of 3 quarters · filed 2021-02-19 | $200.00K 10-K · filed 2021-02-19 | ||
| 2018-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $9.70M derived: sum of 2 quarters · filed 2019-11-07 | $3.20M 10-Q · filed 2019-11-07 | $3.26M 10-Q · filed 2018-11-02 | $4.19M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-06-30 | $6.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $100.00K 10-Q · filed 2019-08-02 | $134.00K 10-Q · filed 2018-08-03 | $1.09M derived: sum of 3 quarters · filed 2020-02-25 | -$1.94M derived: sum of 4 quarters · filed 2020-02-25 | |
| 2018-03-31 | -$6.50M 10-Q · filed 2019-05-08 | -$5.51M derived: sum of 2 quarters · filed 2020-02-25 | -$8.54M derived: sum of 3 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $994.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$2.04M derived: sum of 2 quarters · filed 2020-02-25 | $15.00M 10-K · filed 2020-02-25 | |||
| 2017-09-30 | -$3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $14.01M 10-Q · filed 2018-11-02 | ||||
| 2017-06-30 | $17.04M 10-Q · filed 2018-08-03 | |||||
| 2016-12-31 | $4.60M 10-K · filed 2019-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |